Skip to content

Research & Literature

Last updated:

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature

Visualize citation networks across 133 referenced papers

Top Authors

Top Institutions

References

  1. 1

    Clinical features of Behçet's disease: A retrospective chart review of 26 patients.

    Davari P, Rogers RS, Chan B, et al.

    The Journal of dermatological treatment 2016; (27(1)):70-4 doi:10.3109/09546634.2015.1054781.

    PMID: 26108444
  2. 2

    Association between red blood cell distribution width and disease activity in patients with Behçet's disease.

    Aksoy ŞN, Savaş E, Sucu M, et al.

    The Journal of international medical research 2015; (43(6)):765-73 doi:10.1177/0300060515591063.

    PMID: 26359293
  3. 3

    [An aortic and femoral aneurysm revealing Behçet's disease].

    Lyazidi Y, Abissegue Y, Chtata HT, Taberkant M

    Journal des maladies vasculaires 2015; (40(6)):399-401.

    PMID: 26460187
  4. 4

    Toe Amputation After Minor Surgery in a Patient with Behçet's Disease: A Case Report.

    Özalp B, Akcay C, Aydinol M, Selçuk CT

    The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons 2016; (55(3)):638-41.

    PMID: 26483163
  5. 5

    Management of Behçet's syndrome.

    Ozguler Y, Hatemi G

    Current opinion in rheumatology 2016; (28(1)):45-50 doi:10.1097/BOR.0000000000000231.

    PMID: 26555450
  6. 6

    Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?

    Kim DH, Cheon JH

    Yonsei medical journal 2016; (57(1)):22-32 doi:10.3349/ymj.2016.57.1.22.

    PMID: 26632379
  7. 7

    Behçet's disease, hospital-based prevalence and manifestations in the Rotterdam area.

    Kappen JH, van Dijk EH, Baak-Dijkstra M, et al.

    The Netherlands journal of medicine 2015; (73(10)):471-7.

    PMID: 26687263
  8. 8

    Behçet's disease in black skin. A retrospective study of 50 cases in Dakar.

    Ndiaye M, Sow AS, Valiollah A, et al.

    Journal of dermatological case reports 2015; (9(4)):98-102 doi:10.3315/jdcr.2015.1213.

    PMID: 26848317
  9. 9

    Behçet's disease physiopathology: a contemporary review.

    Zeidan MJ, Saadoun D, Garrido M, et al.

    Auto- immunity highlights 2016; (7(1)):4 doi:10.1007/s13317-016-0074-1.

    PMID: 26868128
  10. 10

    [Aphthous ulcers and oral ulcerations].

    Vaillant L, Samimi M

    Presse medicale (Paris, France : 1983) 2016; (45(2)):215-26.

    PMID: 26880080
  11. 11

    Retinal vasculitis.

    Rosenbaum JT, Sibley CH, Lin P

    Current opinion in rheumatology 2016; (28(3)):228-35 doi:10.1097/BOR.0000000000000271.

    PMID: 26945335
  12. 12

    Behçet's Disease and Nervous System Involvement.

    Kürtüncü M, Tüzün E, Akman-Demir G

    Current treatment options in neurology 2016; (18(5)):19 doi:10.1007/s11940-016-0405-6.

    PMID: 27007988
  13. 13

    Multiple Intracranial Aneurysms Associated with Behçet's Disease.

    Ha S, Kim J, Kim CG, Jang SJ

    Journal of cerebrovascular and endovascular neurosurgery 2016; (18(1)):32-7 doi:10.7461/jcen.2016.18.1.32.

    PMID: 27114964
  14. 14

    Sexual Dysfunction in Male Patients With Behçet's Disease.

    Yıldız M, Batmaz Í, Sula B, et al.

    Acta reumatologica portuguesa 2016; (41(1)):56-61.

    PMID: 27115108
  15. 15

    Behçet's disease and risk of vascular events.

    Balta S, Balta I, Ozturk C, et al.

    Current opinion in cardiology 2016; (31(4)):451-7 doi:10.1097/HCO.0000000000000281.

    PMID: 27152661
  16. 16

    Ophthalmic findings in Behcet׳s disease: Cases without apparent ocular signs.

    Chams H, Mohtasham N, Davatchi F, et al.

    Journal of current ophthalmology 2015; (27(1-2)):46-50 doi:10.1016/j.joco.2015.10.003.

    PMID: 27239575
  17. 17

    Low Level Laser Therapy to Reduce Recurrent Oral Ulcers in Behçet's Disease.

    Babu DB, Chavva S, Waghray S, et al.

    Case reports in dentistry 2016; (2016()):4283986 doi:10.1155/2016/4283986.

    PMID: 27555969
  18. 18

    A missed Behçet's case presenting with spontaneous epidural hematoma.

    Karataş L, Mengi G, Özyemişçi-Taşkıran Ö

    European journal of rheumatology 2015; (2(4)):167-168 doi:10.5152/eurjrheum.2015.0011.

    PMID: 27708958
  19. 19

    Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease.

    Bazvand F, Zarei M, Ebrahimiadib N, et al.

    Seminars in ophthalmology 2017; (32(6)):764-771 doi:10.1080/08820538.2016.1178310.

    PMID: 27715380
  20. 20

    Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet's disease: a retrospective observational study.

    Kirino Y, Ideguchi H, Takeno M, et al.

    Arthritis research & therapy 2016; (18(1)):217 doi:10.1186/s13075-016-1115-x.

    PMID: 27716399
  21. 21

    Asymptomatic Progression of Ocular Behçet's Disease.

    Roizenblatt M, Fares N, Nascimento H, et al.

    Ophthalmic surgery, lasers & imaging retina 2017; (48(1)):18-35 doi:10.3928/23258160-20161219-03.

    PMID: 28060390
  22. 22

    Intestinal Behçet and Crohn's disease: two sides of the same coin.

    Valenti S, Gallizzi R, De Vivo D, Romano C

    Pediatric rheumatology online journal 2017; (15(1)):33 doi:10.1186/s12969-017-0162-4.

    PMID: 28427473
  23. 23

    The Pathergy Test as a Diagnostic Tool.

    Kutlubay Z, Tüzün Y, Wolf R

    Skinmed 2017; (15(2)):97-104.

    PMID: 28528602
  24. 24

    The association of pathergy reaction and active clinical presentations of Behçet's disease.

    Assar S, Sadeghi B, Davatchi F, et al.

    Reumatologia 2017; (55(2)):79-83 doi:10.5114/reum.2017.67602.

    PMID: 28539679
  25. 25

    Management of Behçet's disease.

    Alibaz-Oner F, Sawalha AH, Direskeneli H

    Current opinion in rheumatology 2018; (30(3)):238-242 doi:10.1097/BOR.0000000000000497.

    PMID: 29432223
  26. 26

    2018 update of the EULAR recommendations for the management of Behçet's syndrome.

    Hatemi G, Christensen R, Bang D, et al.

    Annals of the rheumatic diseases 2018; (77(6)):808-818 doi:10.1136/annrheumdis-2018-213225.

    PMID: 29625968
  27. 27

    Behçet's disease: New insights into pathophysiology, clinical features and treatment options.

    Greco A, De Virgilio A, Ralli M, et al.

    Autoimmunity reviews 2018; (17(6)):567-575 doi:10.1016/j.autrev.2017.12.006.

    PMID: 29631062
  28. 28

    Management of vascular Behçet's disease.

    Alibaz-Oner F, Direskeneli H

    International journal of rheumatic diseases 2019; (22 Suppl 1()):105-108 doi:10.1111/1756-185X.13298.

    PMID: 29665281
  29. 29

    Frequency of HLA-B5, HLA-B51 and HLA-B27 in patients with idiopathic uveitis and Behçet's disease: a case-control study.

    Shenavandeh S, Jahanshahi KA, Aflaki E, Tavassoli A

    Reumatologia 2018; (56(2)):67-72 doi:10.5114/reum.2018.75516.

    PMID: 29853720
  30. 30

    Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.

    Bergamo S, di Meo N, Stinco G, et al.

    Acta dermatovenerologica Croatica : ADC 2017; (25(4)):295-297.

    PMID: 30064603
  31. 31

    [False aneurysm of the external iliac artery revealing Behçet's disease].

    Bakkali T, Hormatallah M, Bounssir A, et al.

    Journal de medecine vasculaire 2018; (43(5)):332-334 doi:10.1016/j.jdmv.2018.07.004.

    PMID: 30217350
  32. 32

    Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Behçet's disease.

    Safi R, Kallas R, Bardawil T, et al.

    Journal of dermatological science 2018; (92(2)):143-150 doi:10.1016/j.jdermsci.2018.08.010.

    PMID: 30237006
  33. 33

    Multiorgan involvement of Behçet's disease in a young woman.

    Tamer F, Gülru Erdoğan F, Dinçer Rota D, Yıldırım D

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2018; (27(3)):153-154.

    PMID: 30244267
  34. 34

    An evaluation of depression, anxiety and fatigue in patients with Behçet's disease.

    Can Sandikci S, Colak S, Omma A, Enecik ME

    International journal of rheumatic diseases 2019; (22(6)):974-979 doi:10.1111/1756-185X.13411.

    PMID: 30398004
  35. 35

    Focus on neuro-Behçet's disease: A review.

    Caruso P, Moretti R

    Neurology India 2018; (66(6)):1619-1628 doi:10.4103/0028-3886.246252.

    PMID: 30504554
  36. 36

    Update on the epidemiology, risk factors and disease outcomes of Behçet's disease.

    Akkoç N

    Best practice & research. Clinical rheumatology 2018; (32(2)):261-270 doi:10.1016/j.berh.2018.08.010.

    PMID: 30527431
  37. 37

    Relationship between age at onset and clinical characteristics of Behçet's disease.

    Ghembaza MEA, Lounici A

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2018; (27(4)):175-177.

    PMID: 30564829
  38. 38

    Neuro-Behçet's disease presenting as an isolated progressive cognitive and behavioral syndrome.

    Saracino D, Allegorico L, Barbarulo AM, et al.

    Neurocase 2018; (24(5-6)):238-241 doi:10.1080/13554794.2018.1561898.

    PMID: 30583716
  39. 39

    Update on the treatment of Behçet's syndrome.

    Esatoglu SN, Hatemi G

    Internal and emergency medicine 2019; (14(5)):661-675 doi:10.1007/s11739-019-02035-1.

    PMID: 30684097
  40. 40

    Wrist Drop as a Manifestation of Behçet's Disease.

    Daher A, Haddad F

    European journal of case reports in internal medicine 2017; (4(2)):000512 doi:10.12890/2016_000512.

    PMID: 30755922
  41. 41

    Differentiation between intestinal Behçet’s disease and Crohn’sdisease based on endoscopy

    Ye JF, Guan JL

    Turkish journal of medical sciences 2019; (49(1)):42-49 doi:10.3906/sag-1807-67.

    PMID: 30761850
  42. 42

    The Greek (Hellenic) rheumatology over the years: from ancient to modern times.

    Sakkas LI, Tronzas P

    Rheumatology international 2019; (39(6)):947-955 doi:10.1007/s00296-019-04261-4.

    PMID: 30805680
  43. 43

    Eye and Behçet's disease.

    Ksiaa I, Abroug N, Kechida M, et al.

    Journal francais d'ophtalmologie 2019; (42(4)):e133-e146 doi:10.1016/j.jfo.2019.02.002.

    PMID: 30850197
  44. 44

    [Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study].

    Yong C, Dan L, Chenhong L, et al.

    Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2019; (39(2)):127-133 doi:10.12122/j.issn.1673-4254.2019.02.01.

    PMID: 30890498
  45. 45

    Neuro-Behçet Disease in the Central University Hospital of Asturias.

    Charca-Benavente LC, Gómez de la Torre R, Caminal-Montero L, et al.

    Reumatologia clinica 2021; (17(1)):32-36 doi:10.1016/j.reuma.2019.03.005.

    PMID: 31078455
  46. 46

    Behçet's disease presentations and care outcomes in a tertiary hospital in south-western Saudi Arabia.

    Al Zahrani FM, Alsultan B, Alahmari H, et al.

    International journal of rheumatic diseases 2019; (22(8)):1466-1473 doi:10.1111/1756-185X.13598.

    PMID: 31099192
  47. 47

    Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease.

    Le Joncour A, Martos R, Loyau S, et al.

    Annals of the rheumatic diseases 2019; (78(9)):1274-1282 doi:10.1136/annrheumdis-2018-214335.

    PMID: 31147357
  48. 48

    Early administration of adalimumab for paediatric uveitis due to Behçet's disease.

    Hiyama T, Harada Y, Doi T, Kiuchi Y

    Pediatric rheumatology online journal 2019; (17(1)):29 doi:10.1186/s12969-019-0333-6.

    PMID: 31182107
  49. 49

    High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behçet's disease and their relationship to disease activity.

    Arica DA, Akşan B, Örem A, et al.

    Anais brasileiros de dermatologia 2019; (94(3)):320-326 doi:10.1590/abd1806-4841.20198169.

    PMID: 31365661
  50. 50

    Pediatric Behçet's disease - clinical aspects and current concepts.

    Yıldız M, Köker O, Adrovic A, et al.

    European journal of rheumatology 2020; (7(Suppl1)):S38-S47 doi:10.5152/eurjrheum.2019.19121.

    PMID: 31556871
  51. 51

    Treating the Different Phenotypes of Behçet's Syndrome.

    Bettiol A, Hatemi G, Vannozzi L, et al.

    Frontiers in immunology 2019; (10()):2830 doi:10.3389/fimmu.2019.02830.

    PMID: 31921115
  52. 52

    Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease.

    Bahrini K, Belghith M, Maghrebi O, et al.

    Cytokine 2020; (130()):155054 doi:10.1016/j.cyto.2020.155054.

    PMID: 32151963
  53. 53

    Impact of disease activity on health related quality of life in patients with Behçet's disease: A cross-sectional study.

    Gorial FI, Jabbar MA

    Annals of medicine and surgery (2012) 2020; (54()):43-46 doi:10.1016/j.amsu.2020.03.010.

    PMID: 32368339
  54. 54

    [Uveitis in Behçet's Syndrome in Germany - Prognosis During Current Therapy].

    Stübiger N, Deuter C, Doycheva D

    Klinische Monatsblatter fur Augenheilkunde 2020; (237(5)):591-598 doi:10.1055/a-1140-3295.

    PMID: 32434242
  55. 55

    [Frequency and predictive factors of venous thrombosis in Behçet's disease].

    Ha-Ou-Nou FZ, Essaadouni L

    La Revue de medecine interne 2020; (41(9)):578-582 doi:10.1016/j.revmed.2020.03.010.

    PMID: 32471710
  56. 56

    Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease.

    Hirohata S, Kikuchi H, Sawada T, et al.

    Internal medicine (Tokyo, Japan) 2020; (59(19)):2359-2367 doi:10.2169/internalmedicine.4705-20.

    PMID: 32611961
  57. 57

    Management of patients with Behçet's disease during the COVID-19 pandemic.

    Dursun R, Temiz SA, Özer İ, et al.

    Dermatologic therapy 2020; (33(6)):e14063 doi:10.1111/dth.14063.

    PMID: 32710599
  58. 58

    The Patients' Beliefs Regarding the Role of Food, Mucosal Trauma, Menstruation, and Psychological Stress in the Recurrence of Behçet's Disease Symptoms.

    Shenavandeh S, Asis M, Eftekhari MH, et al.

    Journal of medicine and life 2020; (13(2)):164-169 doi:10.25122/jml-2019-0153.

    PMID: 32742508
  59. 59

    Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet's syndrome: case series and literature review.

    Liu J, Yan D, Wang Z, et al.

    Therapeutic advances in musculoskeletal disease 2020; (12()):1759720X20971908 doi:10.1177/1759720X20971908.

    PMID: 33240406
  60. 60

    Refractory Behçet's Disease with Multi-organ Involvement - Learning from Failure.

    Santos CS, Morales CM, Álvarez ED, Sandoval TP

    Current rheumatology reviews 2021; (17(3)):360-364 doi:10.2174/1573403X16999201228205028.

    PMID: 33371837
  61. 61

    [Ocular manifestations of Behçet's disease].

    Saadouli D, Lahmar A, Ben Mansour K, et al.

    Journal francais d'ophtalmologie 2021; (44(2)):196-202 doi:10.1016/j.jfo.2020.04.058.

    PMID: 33380351
  62. 62

    Isolated brachial artery aneurysm: a rare presentation of paediatric Behçet's disease.

    Naik AL, Savlania A, Gupta A, et al.

    Annals of the Royal College of Surgeons of England 2021; (103(3)):e94-e97 doi:10.1308/rcsann.2020.7037.

    PMID: 33645285
  63. 63

    Behçet's Syndrome Apart From the Triple Symptom Complex: Vascular, Neurologic, Gastrointestinal, and Musculoskeletal Manifestations. A Mini Review.

    Kötter I, Lötscher F

    Frontiers in medicine 2021; (8()):639758 doi:10.3389/fmed.2021.639758.

    PMID: 33898481
  64. 64

    [Acute Neuro-Behçet's Disease].

    Takeuchi H

    Brain and nerve = Shinkei kenkyu no shinpo 2021; (73(5)):560-567 doi:10.11477/mf.1416201799.

    PMID: 34006689
  65. 65

    Pathergy Phenomenon.

    Ergun T

    Frontiers in medicine 2021; (8()):639404 doi:10.3389/fmed.2021.639404.

    PMID: 34113630
  66. 66

    Pulmonary artery thrombosis as the first presentation of Behçet's syndrome: a case report and review of the literature.

    Alakkas Z, Kazi W, Mattar M, et al.

    Journal of medical case reports 2021; (15(1)):322 doi:10.1186/s13256-021-02931-1.

    PMID: 34154640
  67. 67

    [Thrombin generation assay in autoimmune disease].

    Billoir P, Le Cam Duchez V, Miranda S, et al.

    La Revue de medecine interne 2021; (42(12)):862-868 doi:10.1016/j.revmed.2021.06.006.

    PMID: 34175144
  68. 68

    Use of non-TNF biologics for the treatment of neuro-Behçet's disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab.

    Karabulut Y

    European journal of rheumatology 2021; (8(4)):223-227 doi:10.5152/eurjrheum.2021.20160.

    PMID: 34554909
  69. 69

    When obstetrics-gynecology specialists need to call an ophthalmologist urgently: a case report.

    Masmejan S, Guex-Crosier Y, Diserens C, et al.

    Journal of medical case reports 2021; (15(1)):517 doi:10.1186/s13256-021-03087-8.

    PMID: 34670612
  70. 70

    The association of Behçet's syndrome with HLA-B51 as understood in 2021.

    Takeno M

    Current opinion in rheumatology 2022; (34(1)):4-9 doi:10.1097/BOR.0000000000000846.

    PMID: 34690278
  71. 71

    Epidemiological, clinical, and therapeutic characteristics of Behçet's disease: a monocentric study in Tunisia.

    Daoud F, Rachdi I, Somai M, et al.

    The Pan African medical journal 2021; (40()):13 doi:10.11604/pamj.2021.40.13.19146.

    PMID: 34733381
  72. 72

    Adamantiades-Behçet's disease therapy: current treatment options and recommendations with regard to the COVID-19 pandemic.

    Trevisini S, Trevisan G, Zalaudek I, Bonin S

    Dermatologic therapy 2022; (35(3)):e15286 doi:10.1111/dth.15286.

    PMID: 34962035
  73. 73

    Evaluation of sensitivity and specificity of diagnostic criteria for Behçet's disease in the absence of a gold standard.

    Zhong Z, Liao W, Gao Y, et al.

    Rheumatology (Oxford, England) 2022; (61(9)):3667-3676 doi:10.1093/rheumatology/keac018.

    PMID: 35021208
  74. 74

    Behcet's Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and Management.

    Nguyen A, Upadhyay S, Javaid MA, et al.

    Inflammatory intestinal diseases 2021; (6(4)):175-185 doi:10.1159/000520696.

    PMID: 35083283
  75. 75

    Arterial and venous involvement in Behçet's syndrome: a narrative review.

    Toledo-Samaniego N, Oblitas CM, Peñaloza-Martínez E, et al.

    Journal of thrombosis and thrombolysis 2022; (54(1)):162-171 doi:10.1007/s11239-022-02637-1.

    PMID: 35182310
  76. 76

    Presence of neutrophil extracellular traps in superficial venous thrombosis of Behçet's disease.

    Kawakami T, Yokoyama K, Ikeda T, et al.

    The Journal of dermatology 2022; (49(7)):741-745 doi:10.1111/1346-8138.16391.

    PMID: 35434809
  77. 77

    HLA-B51 Impact on Clinical Symptoms in Behcet's Disease.

    Pamukcu M, Duran TI, Demirag MD

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2022; (32(7)):904-908 doi:10.29271/jcpsp.2022.07.904.

    PMID: 35795941
  78. 78

    Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study.

    Hatemi G, Mahr A, Takeno M, et al.

    RMD open 2022; (8(2)) doi:10.1136/rmdopen-2022-002235.

    PMID: 35798511
  79. 79

    Predictive Factors of Severe Behçet's disease: A Longitudinal, Prospective Cohort Followed Between 1981-2020.

    Serpa Pinto L, Xavier Pires S, Silva B, et al.

    Reumatologia clinica 2022; (18(7)):410-415 doi:10.1016/j.reumae.2021.03.011.

    PMID: 35940675
  80. 80

    Behçet uveitis: Current practice and future perspectives.

    Aboul Naga SH, Hassan LM, El Zanaty RT, et al.

    Frontiers in medicine 2022; (9()):968345 doi:10.3389/fmed.2022.968345.

    PMID: 36160151
  81. 81

    Mucocutaneous manifestations of Behçet's disease: Pathogenesis and management from perspectives of vasculitis.

    Kim D, Nakamura K, Kaneko F, et al.

    Frontiers in medicine 2022; (9()):987393 doi:10.3389/fmed.2022.987393.

    PMID: 36530905
  82. 82

    Vascular Behçet syndrome: from pathogenesis to treatment.

    Bettiol A, Alibaz-Oner F, Direskeneli H, et al.

    Nature reviews. Rheumatology 2023; (19(2)):111-126 doi:10.1038/s41584-022-00880-7.

    PMID: 36544027
  83. 83

    The Role of Colchicine in Different Clinical Phenotypes of Behcet Disease.

    Wang Z, Zu X, Xiong S, et al.

    Clinical therapeutics 2023; (45(2)):162-176 doi:10.1016/j.clinthera.2023.01.004.

    PMID: 36732153
  84. 84

    Reduction of Neutrophil Activation by Phosphodiesterase 4 Blockade in Behçet's Disease.

    Le Joncour A, Régnier P, Maciejewski-Duval A, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(9)):1628-1637 doi:10.1002/art.42486.

    PMID: 36862398
  85. 85

    Intestinal Behcet's Disease: A Review of the Immune Mechanism and Present and Potential Biological Agents.

    He K, Yan X, Wu D

    International journal of molecular sciences 2023; (24(9)) doi:10.3390/ijms24098176.

    PMID: 37175882
  86. 86

    Clinical Manifestations of Behçet's Disease: A Retrospective Cross-Sectional Study.

    Sadeghi A, Rostami M, Amraei G, et al.

    Mediterranean journal of rheumatology 2023; (34(1)):53-60 doi:10.31138/mjr.34.1.53.

    PMID: 37223587
  87. 87

    Challenges in the Timely Diagnosis of Behcet's Disease.

    Hassan F, Jeries H, Naffaa ME

    Life (Basel, Switzerland) 2023; (13(5)) doi:10.3390/life13051157.

    PMID: 37240802
  88. 88

    Case of elderly onset possible neuro-Behçet's disease with HLA-B51 homozygosity.

    Shiraishi W, Tsujimoto Y, Matsuyoshi A, Hashimoto T

    BMJ case reports 2023; (16(6)) doi:10.1136/bcr-2022-252033.

    PMID: 37263675
  89. 89

    Clinical trait-specific genetic analysis in Behçet's disease identifies novel loci associated with ocular and neurological involvement.

    Casares-Marfil D, Esencan D, Alibaz-Oner F, et al.

    Clinical immunology (Orlando, Fla.) 2023; (253()):109657 doi:10.1016/j.clim.2023.109657.

    PMID: 37271218
  90. 90

    [Hughes-Stovin syndrome: a life-threatening manifestation of Behçet's syndrome].

    Ruffer N, Krusche M, Holl-Ulrich K, et al.

    Zeitschrift fur Rheumatologie 2024; (83(4)):327-333 doi:10.1007/s00393-023-01371-0.

    PMID: 37280333
  91. 91

    Behçet's disease uveitis.

    Joubert M, Desbois AC, Domont F, et al.

    La Revue de medecine interne 2023; (44(10)):546-554 doi:10.1016/j.revmed.2023.06.004.

    PMID: 37414674
  92. 92

    Advances in Management of Intestinal Behçet's Disease: A Perspective From Gastroenterologists.

    Cheon JH

    Journal of rheumatic diseases 2021; (28(1)):4-16 doi:10.4078/jrd.2021.28.1.4.

    PMID: 37476392
  93. 93

    Vasculo-Behçet's disease with a giant pseudoaneurysm of superficial femoral artery: A case report.

    Al-Doud MA, Al-Nusairat AN, Al-Shanableh NM, et al.

    International journal of surgery case reports 2023; (109()):108534 doi:10.1016/j.ijscr.2023.108534.

    PMID: 37524014
  94. 94

    Neuro-Behcet's disease misdiagnosed and treated as multiple sclerosis: a deceiving masquerader.

    Algahtani H, Shirah B, Almohiy H, AlAlmai A

    The International journal of neuroscience 2024; (134(10)):1134-1138 doi:10.1080/00207454.2023.2246099.

    PMID: 37548488
  95. 95

    Adamantiades-Behçet disease: Between dermatology and ophthalmology.

    Grzybowski A, Pawlikowska-Łagód K, Altenburg A, Zouboulis CC

    Clinics in dermatology 2023; (41(4)):469-475 doi:10.1016/j.clindermatol.2023.08.001.

    PMID: 37572969
  96. 96

    [An update on Behçet's syndrome].

    Xenitidis T, Henes JC

    Deutsche medizinische Wochenschrift (1946) 2023; (148(17)):1129-1134 doi:10.1055/a-1958-2338.

    PMID: 37611579
  97. 97

    Concurrent Pulmonary Artery Aneurysm, Pulmonary Thrombosis, and Intracardiac Thrombus in Behçet's Disease: A Case Report.

    Alagha OA, Abu ElQomboz AY, Alsarafandi SF

    Cureus 2023; (15(8)):e43993 doi:10.7759/cureus.43993.

    PMID: 37746357
  98. 98

    Unfolding dermatologic spectrum of Behçet's disease in Italy: real-life data from the International AIDA Network Behçet's disease Registry.

    D'Onghia M, Cinotti E, Cartocci A, et al.

    Internal and emergency medicine 2023; (18(8)):2245-2252 doi:10.1007/s11739-023-03410-9.

    PMID: 37803193
  99. 99

    Vascular Involvement in Behcet's Disease: An Evaluation of 147 Cases and Literature Review.

    Atalar E, Erten S, Dogan I, Konak HE

    Sisli Etfal Hastanesi tip bulteni 2023; (57(3)):380-386 doi:10.14744/SEMB.2023.89083.

    PMID: 37900329
  100. 100

    Pulmonary Artery Aneurysm in Behcet Disease: Medical, Endovascular or Surgical Intervention.

    Samreen I, Darji P, Genobaga S, et al.

    Cureus 2023; (15(11)):e49368 doi:10.7759/cureus.49368.

    PMID: 38146562
  101. 101

    [An update on Behçet's syndrome].

    Xenitidis T, Henes JC

    Laryngo- rhino- otologie 2024; (103(5)):352-357 doi:10.1055/a-2249-2116.

    PMID: 38330997
  102. 102

    Does anticoagulation in combination with immunosuppressive therapy prevent recurrent thrombosis in Behçet's disease?

    Erol S, Gürün Kaya A, Arslan F, et al.

    Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2024; (72(4)):387-391 doi:10.1177/10815589241232368.

    PMID: 38357865
  103. 103

    Pan-immune-inflammation value could be a new marker to differentiate between vascular Behçet's disease and non-vascular Behçet's disease.

    Ocak T, Lermı N, Yılmaz Bozkurt Z, et al.

    European review for medical and pharmacological sciences 2024; (28(5)):1751-1759 doi:10.26355/eurrev_202403_35588.

    PMID: 38497857
  104. 104

    Blue Toe Syndrome in Behçet's Disease: A Case Report.

    Aljarrah Q, Ba-Shammakh SA, Allouh MZ, Afaneh MW

    The American journal of case reports 2024; (25()):e943813 doi:10.12659/AJCR.943813.

    PMID: 38907515
  105. 105

    Cardiovascular Manifestations in Behçet's Disease.

    Kim J

    Yonsei medical journal 2024; (65(9)):493-500 doi:10.3349/ymj.2023.0578.

    PMID: 39193757
  106. 106

    Anti-TCP1 Antibody Is a Potential Biomarker for Diagnosing Systemic Lupus Erythematosus.

    Lee SW, Baek WY, Park SW, et al.

    International journal of molecular sciences 2024; (25(16)) doi:10.3390/ijms25168612.

    PMID: 39201300
  107. 107

    The Current and Novel Imaging Modalities for Ocular Vasculitis in Behcet's Disease: A Review.

    Kaur M, Yip K

    Cureus 2024; (16(9)):e69528 doi:10.7759/cureus.69528.

    PMID: 39416569
  108. 108

    Infliximab versus Cyclophosphamide for Severe Behçet's Syndrome.

    Saadoun D, Maalouf G, Vieira M, et al.

    NEJM evidence 2024; (3(11)):EVIDoa2300354 doi:10.1056/EVIDoa2300354.

    PMID: 39437137
  109. 109

    Dyspnea and hemoptysis revealing Behçet's syndrome: Pulmonary artery aneurysms in a case report.

    Ez-Zaky S, Laasri I, Jroundi L, Laamrani FZ

    Radiology case reports 2025; (20(1)):115-118 doi:10.1016/j.radcr.2024.09.110.

    PMID: 39484046
  110. 110

    Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry.

    Sota J, Ragab G, AlMaglouth I, et al.

    Joint bone spine 2025; (92(2)):105819 doi:10.1016/j.jbspin.2024.105819.

    PMID: 39549971
  111. 111

    Neuro-Behçet leading to coma: A case report.

    Kriouile S, Imrani K, Graini SE, et al.

    Radiology case reports 2025; (20(1)):625-628 doi:10.1016/j.radcr.2024.10.102.

    PMID: 39583234
  112. 112

    A20 haploinsufficiency diagnosis beyond systemic lupus erythematosus: A systematic review of the literature.

    Philip R, Elhani I, Gallou S, et al.

    Autoimmunity reviews 2025; (24(2)):103722 doi:10.1016/j.autrev.2024.103722.

    PMID: 39672252
  113. 113

    Long-Term Outcomes of Uveoretinitis in Behçet's Disease in the Era of Biologic Treatments: A 10-Year Follow-Up Study.

    Sugawara R, Usui Y, Tsubota K, Goto H

    Ocular immunology and inflammation 2025; (33(6)):913-919 doi:10.1080/09273948.2025.2467435.

    PMID: 39980310
  114. 114

    Incidence and prevalence of Behçet's disease in Oslo, Norway: a two-decade population-based analysis.

    Lorentsen JLL, Brunborg C, Aasebø AT, et al.

    Rheumatology (Oxford, England) 2025; (64(8)):4703-4712 doi:10.1093/rheumatology/keaf224.

    PMID: 40279276
  115. 115

    Clinical and imaging features of parenchymal and non-parenchymal neuro-Behçet's disease: a systematic review of case reports and series.

    Al-Omoush O, AlBarakat MM, Alasmar D, et al.

    BMC neurology 2025; (25(1)):225 doi:10.1186/s12883-025-04250-0.

    PMID: 40419971
  116. 116

    Inflammatory cerebral pseudotumour as a rare manifestation of neuro-Behçet's disease: A case report and literature review.

    Porto Fuentes Ó, Lacruz Ballester L, Álvarez Troncoso J, et al.

    Journal of neuroimmunology 2025; (405()):578652 doi:10.1016/j.jneuroim.2025.578652.

    PMID: 40446741
  117. 117

    Successful Treatment of Refractory Mucocutaneous Behçet's Disease With Gastrointestinal Involvement Using Anti-tumor Necrosis Factor-Alpha (Anti-TNF-α) Therapy.

    Elfatih Mohamed M, Mazin Al-Issa R, Ahmed H, et al.

    Cureus 2025; (17(5)):e84937 doi:10.7759/cureus.84937.

    PMID: 40585706
  118. 118

    Predictors of anti-TNF treatment failure in intestinal Behçet's disease: a multicenter retrospective cohort study.

    Xu W, Wu X, Yu Q, et al.

    Clinical rheumatology 2025; (44(9)):3655-3665 doi:10.1007/s10067-025-07581-y.

    PMID: 40668289
  119. 119

    MRI findings in neuro-Behçet's disease. About 104 moroccan patients and literature review.

    Oumerzouk J, Hafidi J, Abdellaoui M, et al.

    Multiple sclerosis and related disorders 2025; (102()):106638 doi:10.1016/j.msard.2025.106638.

    PMID: 40737963
  120. 120

    Anticoagulants and immunosuppressive therapy for thrombosis in Behçet's syndrome: a systematic review and meta-analysis.

    Chuklin A, Chiasakul T, Uaprasert N

    Journal of thrombosis and haemostasis : JTH 2025; (23(11)):3578-3589 doi:10.1016/j.jtha.2025.07.025.

    PMID: 40769432
  121. 121

    Behçet's Disease In Children And Adults Of Sub-Saharan Ancestry: A Systematic Review And Meta-Analysis.

    Suzon B, Felix A, Louis-Sidney F, et al.

    Clinical reviews in allergy & immunology 2025; (68(1)):81 doi:10.1007/s12016-025-09085-8.

    PMID: 40810771
  122. 122

    Widespread venous thrombosis: Unveiling a complex case of Behçet's disease with a literature perspective.

    Liu B, Tan C

    Open medicine (Warsaw, Poland) 2025; (20(1)):20251199 doi:10.1515/med-2025-1199.

    PMID: 40823180
  123. 123

    Neutropenic Enterocolitis in Acute Myeloid Leukemia and Morbus Behcet: Pivotal Role of Medical Imaging and Multidisciplinary Management in a Complex Clinical Case.

    Dascalescu CA, Fraccaroli A, Gaitzsch E, et al.

    In vivo (Athens, Greece) 2025; (39(5)):3008-3013 doi:10.21873/invivo.14102.

    PMID: 40877152
  124. 124

    Promoting patients' empowerment in rheumatic diseases: the perspective of the International Society of Behçet's Disease Working Group on Patient Empowerment, Adherence to Therapy and Patients' Education.

    Di Cianni F, Marinello D, Altenburg A, et al.

    Clinical and experimental rheumatology 2025; (43(10)):1810-1815 doi:10.55563/clinexprheumatol/rk42aa.

    PMID: 40924663
  125. 125

    Relationship between dermatological quality of life, disease activity, depression, and anxiety levels in Behçet's syndrome: a structural equation modelling approach.

    Karacan Y, Akkus Y, Kasap K, Unlu K

    Psychology, health & medicine 2025; 1-15 doi:10.1080/13548506.2025.2565518.

    PMID: 41004688
  126. 126

    [Surgical Resection of an Ascending Colon Tumor Suspected to Represent Intestinal Behçet's Disease-A Case Report].

    Funaoka K, Yamada R, Hatayama R, et al.

    Gan to kagaku ryoho. Cancer & chemotherapy 2025; (52(10)):761-763.

    PMID: 41139976
  127. 127

    Carotid artery aneurysm as the initial presentation of Behçet's disease: A case report.

    Bengrad A, Laarouchi A, Ouhmich M, et al.

    Journal of vascular surgery cases and innovative techniques 2026; (12(1)):102011 doi:10.1016/j.jvscit.2025.102011.

    PMID: 41323528
  128. 128

    Behçet's disease unraveled: Insights into clinical manifestations, diagnosis, and management.

    Alghamdi M, Lindsey S

    Medicine 2025; (104(49)):e44614 doi:10.1097/MD.0000000000044614.

    PMID: 41367023
  129. 129

    Clinical Features of Behçet's Disease Uveitis.

    Yalçindag N, Oklar M

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2025; (39(4)):290-298 doi:10.4103/sjopt.sjopt_163_24.

    PMID: 41367832
  130. 130

    Intestinal Behçet's disease presenting with intestinal obstruction misdiagnosed as Crohn's disease: a case report.

    Song J, Zeng LH, Lv WY, et al.

    Journal of medical case reports 2025; (20(1)):31 doi:10.1186/s13256-025-05749-3.

    PMID: 41387906
  131. 131

    Behçet's Disease Mimicking Drug-Induced Mucocutaneous Lesions in a Patient on Anti-tuberculous Drugs.

    Batool M, Akram I, Babar F, et al.

    Cureus 2025; (17(11)):e96922 doi:10.7759/cureus.96922.

    PMID: 41409967
  132. 132

    Adalimumab-Associated Transverse Myelitis Revealing Relapsing-Remitting Multiple Sclerosis in a Patient With Crohn's Disease: A Case Report.

    Gawargeous SS, Elsahy T

    Cureus 2025; (17(11)):e97651 doi:10.7759/cureus.97651.

    PMID: 41450349
  133. 133

    Localised Herpes Simplex Following Midline Laparotomy.

    Bulluss JS, Chee P, Verheyden MJ

    The Medical journal of Australia 2026; (224(1)):e70122 doi:10.5694/mja2.70122.

    PMID: 41486961